Nan Fung Group Holdings »

Merus N V shares owned by Nan Fung Group Holdings

Quarter-by-quarter ownership of Merus N V (MRUS) shares owned by Nan Fung Group Holdings from 13F filings

Historical chart of Nan Fung Group Holdings investment in Merus N V

Tip: Access up to 7 years of quarterly data

All positions including Merus N V held by Nan Fung Group Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Merus N V by Nan Fung Group Holdings

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.2M 137k 23.58
2023-06-30 $4.0M 151k 26.33
2023-03-31 $2.8M 151k 18.40
2022-12-31 $1.5M 94k 15.47

More positions owned by Nan Fung Group Holdings

Karuna Therapeutics Ord
Illumina (ILMN)
Harmony Biosciences Hldgs In (HRMY)
Seagen
Oculis Holding Ordinary Shares (OCS)
Somalogic Class A Com
Exscientia Ads (EXAI)
Xenon Pharmaceuticals (XENE)
Merus N V (MRUS)
Replimune Group (REPL)
Kalvista Pharmaceuticals (KALV)
Beigene Sponsored Adr (BGNE)
Alpine Immune Sciences (ALPN)
Incyte Corporation (INCY)
Geron Corporation (GERN)

View all positions for Nan Fung Group Holdings

Top funds holding Merus N V

Commodore Capital
Federated Investors
Samlyn Capital
Deerfield Management Company
BVF
VR Adviser
Wellington Management Company
Boxer Capital
Franklin Resources
Balyasny Asset Management
Medicxi Ventures Management
Lynx1 Capital Management
venBio Select Advisor
Frazier Life Sciences Management
Fairmount Funds Management

View all funds holding Merus N V